Table 2 Comparison of cytological diagnosis of cervical lymphadenopathy between patients with and without HIV infection
Diagnosis | HIV positive patients(cases) | HIV negative patients(cases) | Total | P value | P value a |
|---|---|---|---|---|---|
Benign lesions | |||||
 Reactive lymphoid hyperplasia | 131(28.9%) | 51(37.5%) | 182 | 0.058 | 0.232 |
 Non-specific inflammation | 90(19.9%) | 26(19.1%) | 116 | 0.847 | 0.397 |
 Suppurative lymphadenitis | 11(2.4%) | 8(5.9%) | 19 | 0.046 | 0.282 |
 Granulomatous lymphadenitis | 5(1.1%) | 0 | 5 | 0.219 | 0.995 |
 Kikuchi disease | 1(0.2%) | 1(0.7%) | 2 | 0.364 | 0.726 |
 Opportunistic infections | 190(41.9%) | 17(12.5%) | 207 | 0.000 | < 0.001 |
 Mycobacterial infection | 174(38.4%) | 17(12.5%) | 191 | 0.000 | < 0.001 |
 Tuberculosis | 155(34.2%) | 17(12.5%) | 172 | 0.000 | < 0.001 |
 Nontuberculous mycobacteria | 19(4.2%) | 0(4.2%) | 19 | 0.015 | 0.996 |
 Cryptococcosis | 7(1.5%) | 0 | 7 | 0.145 |  |
 Talaromyces marneffei | 7(1.5%) | 0 | 7 | 0.145 |  |
 Other fungus | 2(0.4%) | 0 | 2 | 0.438 |  |
 Epidermal inclusion cyst | 2(0.4%) | 4(2.9%) | 6 | 0.011 | 0.008 |
 Lipoma | 1(0.2%) | 0 | 1 | 0.583 | 0.994 |
 Vascular lesions | 0 | 1(0.7%) | 1 | 0.068 | 0.993 |
Malignant lesions | |||||
 lymphoma | 12(2.6%) | 9(6.6%) | 21 | 0.029 | 0.296 |
 Hodgkin lymphoma | 1(0.2%) | 0 | 1 | 0.583 |  |
 Non Hodgkin lymphoma | 11(2.4%) | 9(6.6%) | 20 | 0.018 | 0.223 |
 Kaposi’s sarcoma | 4(0.9%) | 0 | 4 | 0.272 | 0.996 |
 Metastatic carcinoma | 3(0.7%) | 19(14%) | 22 | 0.000 | < 0.001 |
 squamous cell carcinoma | 3(0.7%) | 12(8.8%) | 15 | 0.000 | 0.003 |
 adenocarcinoma | 0 | 3(2.2%) | 3 | 0.002 | 0.993 |
 small cell carcinoma | 0 | 3(2.2%) | 3 | 0.002 | 0.993 |
 hepatocellular carcinoma | 0 | 1(0.7%) | 1 | 0.068 |  |
Unsatisfactory aspirates | 3(0.7%) | 0 | 3 | 0.341 | 0.996 |
Total | 453 | 136 | 589 | – |  |